Award
University of Colorado Boulder 1002172200
Tri-Methyl-Histone H3 (Lys36) (D5A7) XP Rabbit mAb; Mono-Methyl-Histone H3 (Lys27) (D3R8N) Rabbit mAb; Di-Methyl-Hist...
Recipient
Cell Signaling Technology Inc
Award Amount
$1,111.35
Ceiling
$1,111.35
Awarded
August 05, 2025
Identifier
1002172200
The University of Colorado Boulder, a public college or university located in Colorado, awarded a contract to Cell Signaling Technology Inc to purchase four monoclonal antibodies related to histone modifications. The procurement was for laboratory research reagents, with a total amount of $1,111.35, and was conducted on August 5, 2025. The contract covers four specific antibody products described as Tri-Methyl-Histone H3 (Lys36), Mono-Methyl-Histone H3 (Lys27), Di-Methyl-Histone H3 (Lys27), and Acetyl-Histone H4 (Lys16), each with specific unit prices and quantities. The award was a single-transaction purchase and does not specify multi-year or renewal terms.
Description
Tri-Methyl-Histone H3 (Lys36) (D5A7) XP Rabbit mAb; Mono-Methyl-Histone H3 (Lys27) (D3R8N) Rabbit mAb; Di-Methyl-Histone H3 (Lys27) (D18C8) XP Rabbit mAb; Acetyl-Histone H4 (Lys16) (E2B8W) Rabbit mAb